Purinergic implication in amyotrophic lateral sclerosis—from pathological mechanisms to therapeutic perspectives
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1573-9546
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Purinergic implication in amyotrophic lateral sclerosis—from pathological mechanisms to therapeutic perspectives ; day:14 ; month:11 ; year:2018 ; pages:1-15
Purinergic signalling ; (14.11.2018), 1-15
- Creator
-
Cieślak, M.
Roszek, K.
Wujak, M.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s11302-018-9633-4
- URN
-
urn:nbn:de:101:1-2018123020001838983653
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:57 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Cieślak, M.
- Roszek, K.
- Wujak, M.
- SpringerLink (Online service)
Other Objects (12)
Amyotrophic lateral sclerosis
Pathological insights from amyotrophic lateral sclerosis animal models: comparisons, limitations, and challenges
Pathological Modification of TDP-43 in Amyotrophic Lateral Sclerosis with SOD1 Mutations
FUS/TLS deficiency causes behavioral and pathological abnormalities distinct from amyotrophic lateral sclerosis
Update on the pathological roles of prostaglandin E2 in neurodegeneration in amyotrophic lateral sclerosis
Amyotrophic lateral sclerosis and cerebellum
Genetics of Amyotrophic Lateral Sclerosis
Co-morbidity of progressive supranuclear palsy and amyotrophic lateral sclerosis: a clinical-pathological case report
Immunochemical characterization on pathological oligomers of mutant Cu/Zn-superoxide dismutase in amyotrophic lateral sclerosis
Recent advances in amyotrophic lateral sclerosis
Metabolic Reprogramming in Amyotrophic Lateral Sclerosis
Neuroimaging Endpoints in Amyotrophic Lateral Sclerosis
Amyotrophic lateral sclerosis
Pathological insights from amyotrophic lateral sclerosis animal models: comparisons, limitations, and challenges
Pathological Modification of TDP-43 in Amyotrophic Lateral Sclerosis with SOD1 Mutations
FUS/TLS deficiency causes behavioral and pathological abnormalities distinct from amyotrophic lateral sclerosis
Update on the pathological roles of prostaglandin E2 in neurodegeneration in amyotrophic lateral sclerosis
Amyotrophic lateral sclerosis and cerebellum
Genetics of Amyotrophic Lateral Sclerosis
Co-morbidity of progressive supranuclear palsy and amyotrophic lateral sclerosis: a clinical-pathological case report
Immunochemical characterization on pathological oligomers of mutant Cu/Zn-superoxide dismutase in amyotrophic lateral sclerosis
Recent advances in amyotrophic lateral sclerosis
Metabolic Reprogramming in Amyotrophic Lateral Sclerosis
Neuroimaging Endpoints in Amyotrophic Lateral Sclerosis
Amyotrophic lateral sclerosis
Pathological insights from amyotrophic lateral sclerosis animal models: comparisons, limitations, and challenges
Pathological Modification of TDP-43 in Amyotrophic Lateral Sclerosis with SOD1 Mutations
FUS/TLS deficiency causes behavioral and pathological abnormalities distinct from amyotrophic lateral sclerosis
Update on the pathological roles of prostaglandin E2 in neurodegeneration in amyotrophic lateral sclerosis
Amyotrophic lateral sclerosis and cerebellum
Genetics of Amyotrophic Lateral Sclerosis
Co-morbidity of progressive supranuclear palsy and amyotrophic lateral sclerosis: a clinical-pathological case report
Immunochemical characterization on pathological oligomers of mutant Cu/Zn-superoxide dismutase in amyotrophic lateral sclerosis
Recent advances in amyotrophic lateral sclerosis
Metabolic Reprogramming in Amyotrophic Lateral Sclerosis